Estradiol potentiates 8-OH-DPAT-induced sumoylation of 5-HT1A receptor: Characterization and subcellular distribution of sumoylated 5-HT1A receptors

Psychoneuroendocrinology

Volumn 38, Issue 11, 2013, Pages 2542-2553

  Li, Qian ^a,b   Muma, Nancy A ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endoplasmic reticulum; Estradiol; Fluoxetine; Hypothalamus; Lipid raft; SUMO1

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; CELL PROTEIN; ESTRADIOL; G ALPHA Z PROTEIN; G PROTEIN COUPLED RECEPTOR; SEROTONIN 1A RECEPTOR; SUMO 1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; BRAIN REGION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DESENSITIZATION; ENDOPLASMIC RETICULUM; FEMALE; HYPOTHALAMUS; INTERNALIZATION; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; RAT; SIGNAL TRANSDUCTION; SUMOYLATION; TRANS GOLGI NETWORK;

ENDOPLASMIC RETICULUM; ESTRADIOL; FLUOXETINE; HYPOTHALAMUS; LIPID RAFT; SUMO1;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; BRAIN; CELL MEMBRANE; DRUG SYNERGISM; ENDOPLASMIC RETICULUM; ESTRADIOL; ESTROGENS; FEMALE; FLUOXETINE; GOLGI APPARATUS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTORS, G-PROTEIN-COUPLED; SEROTONIN 5-HT1 RECEPTOR AGONISTS; SEROTONIN UPTAKE INHIBITORS; SUBCELLULAR FRACTIONS; SUMOYLATION;

EID: 84886100716     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2013.05.016     Document Type: Article

References (51)

1. Achour L., Labbe-Jullie C., Scott M.G., Marullo S. An escort for GPCRs: implications for regulation of receptor density at the cell surface. Trends Pharmacol. Sci. 2008, 29:528-535.
2. Akimova E., Lanzenberger R., Kasper S. The serotonin-1A receptor in anxiety disorders. Biol. Psychiatry 2009, 66:627-635.
3. Allen J.A., Halverson-Tamboli R.A., Rasenick M.M. Lipid raft microdomains and neurotransmitter signalling. Nat. Rev. Neurosci. 2007, 8:128-140.
4. Anderson D.B., Wilkinson K.A., Henley J.M. Protein SUMOylation in neuropathological conditions. Drug News Perspect. 2009, 22:255-265.
5. Andreou A.M., Tavernarakis N. SUMOylation and cell signalling. Biotechnol. J. 2009, 4:1740-1752.
6. Artigas F., Celada P., Laruelle M., Adell A. How does pindolol improve antidepressant action?. Trends Pharmacol. Sci. 2001, 22:224-228.
7. Bethea C.L., Gundlah C., Mirkes S.J. Ovarian steroid action in the serotonin neural system of macaques. Novartis Found. Symp. 2000, 230:112-130.
8. Blier P., Abbott F.V. Putative mechanisms of action of antidepressant drugs in affective and anxiety disorders and pain. J. Psychiatry Neurosci. 2001, 26:37-43.
9. Castle J.D. Purification of Organelles from Mammalian Cells. Current Protocols in Protein Science/Editorial Board 2004, John E. Coligan et al. Chapter 4, Unit 4 2.
10. Chamberlain S.E., Gonzalez-Gonzalez I.M., Wilkinson K.A., Konopacki F.A., Kantamneni S., Henley J.M., Mellor J.R. SUMOylation and phosphorylation of GluK2 regulate kainate receptor trafficking and synaptic plasticity. Nat. Neurosci. 2012, 15:845-852.
11. Cheng S.B., Quinn J.A., Graeber C.T., Filardo E.J. Down-modulation of the G-protein-coupled estrogen receptor, GPER, from the cell surface occurs via a trans-Golgi-proteasome pathway. J. Biol. Chem. 2011, 286:22441-22455.
12. Chini B., Parenti M. G-protein coupled receptors in lipid rafts and caveolae: how, when and why do they go there. J. Mol. Endocrinol. 2004, 32:325-338.
13. Craig T.J., Henley J.M. Protein SUMOylation in spine structure and function. Curr. Opin. Neurobiol. 2012, 22:480-487.
14. Creech R.D., Li Q., Carrasco G.A., Van de Kar L.D., Muma N.A. Estradiol induces partial desensitization of serotonin 1A receptor signaling in the paraventricular nucleus of the hypothalamus and alters expression and interaction of RGSZ1 and Galphaz. Neuropharmacology 2012, 62:2040-2049.
15. Dutting E., Schroder-Kress N., Sticht H., Enz R. SUMO E3 ligases are expressed in the retina and regulate SUMOylation of the metabotropic glutamate receptor 8b. Biochem. J. 2011, 435:365-371.
16. Enz R. Structure of metabotropic glutamate receptor C-terminal domains in contact with interacting proteins. Front. Mol. Neurosci. 2012, 5:52.
17. Felberbaum R., Wilson N.R., Cheng D., Peng J., Hochstrasser M. Desumoylation of the endoplasmic reticulum membrane VAP family protein Scs2 by Ulp1 and SUMO regulation of the inositol synthesis pathway. Mol. Cell. Biol. 2012, 32:64-75.
18. Fuhs S.R., Insel P.A. Caveolin-3 undergoes SUMOylation by the SUMO E3 ligase PIASy: sumoylation affects G-protein-coupled receptor desensitization. J. Biol. Chem. 2011, 286:14830-14841.
19. Gareau J.R., Lima C.D. The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition. Nat. Rev. Mol. Cell Biol. 2010, 11:861-871.
20. Geiss-Friedlander R., Melchior F. Concepts in sumoylation: a decade on. Nat. Rev. Mol. Cell Biol. 2007, 8:947-956.
21. Gowran A., Murphy C.E., Campbell V.A. Delta(9)-tetrahydrocannabinol regulates the p53 post-translational modifiers murine double minute 2 and the Small Ubiquitin MOdifier protein in the rat brain. FEBS Lett. 2009, 583:3412-3418.
22. Gross C., Santarelli L., Brunner D., Zhuang X.X., Hen R. Altered fear circuits in 5-HT1A receptor KO mice. Biol. Psychiatry 2000, 48:1157-1163.
23. Jiang Z., Fan Q., Zhang Z., Zou Y., Cai R., Wang Q., Zuo Y., Cheng J. SENP1 deficiency promotes ER stress-induced apoptosis by increasing XBP1 SUMOylation. Cell Cycle 2012, 11:1118-1122.
24. Kellert B.A., Nguyen M.C., Nguyen C., Nguyen Q.H., Wagner E.J. Estrogen rapidly attenuates cannabinoid-induced changes in energy homeostasis. Eur. J. Pharmacol. 2009, 622:15-24.
25. Kelly M.J., Loose M.D., Ronnekleiv O.K. Estrogen suppresses mu-opioid- and GABAB-mediated hyperpolarization of hypothalamic arcuate neurons. J. Neurosci. 1992, 12:2745-2750.
26. Kobe F., Renner U., Woehler A., Wlodarczyk J., Papusheva E., Bao G., Zeug A., Richter D.W., Neher E., Ponimaskin E. Stimulation- and palmitoylation-dependent changes in oligomeric conformation of serotonin 5-HT1A receptors. Biochim. Biophys. Acta 2008, 1783:1503-1516.
27. Konopacki F.A., Jaafari N., Rocca D.L., Wilkinson K.A., Chamberlain S., Rubin P., Kantamneni S., Mellor J.R., Henley J.M. Agonist-induced PKC phosphorylation regulates GluK2 SUMOylation and kainate receptor endocytosis. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:19772-19777.
28. Kumari R., Francesconi A. Identification of GPCR localization in detergent resistant membranes. Methods Mol. Biol. 2011, 746:411-423.
29. Lagrange A.H., Wagner E.J., Ronnekleiv O.K., Kelly M.J. Estrogen rapidly attenuates a GABAB response in hypothalamic neurons. Neuroendocrinology 1996, 64:114-123.
30. Li Q., Brownfield M.S., Levy A.D., Battaglia G., Cabrera T.M., Van de Kar L.D. Attenuation of hormone responses to the 5-HT1A agonist ipsapirone by long-term treatment with fluoxetine, but not desipramine, in male rats. Biol. Psychiatry 1994, 36:300-308.
31. Li Q., Sullivan N.R., McAllister C.E., Van de Kar L.D., Muma N.A. Estradiol accelerates the effects of fluoxetine on serotonin 1A receptor signaling. Psychoneuroendocrinology 2013, 38:1145-1157.
32. Majumdar A., Petrescu A.D., Xiong Y., Noy N. Nuclear translocation of cellular retinoic acid-binding protein II is regulated by retinoic acid-controlled SUMOylation. J. Biol. Chem. 2011, 286:42749-42757.
33. Mao L.M., Guo M.L., Jin D.Z., Fibuch E.E., Choe E.S., Wang J.Q. Post-translational modification biology of glutamate receptors and drug addiction. Front. Neuroanat. 2011, 5:19.
34. Martin S., Wilkinson K.A., Nishimune A., Henley J.M. Emerging extranuclear roles of protein SUMOylation in neuronal function and dysfunction. Nat. Rev. Neurosci. 2007, 8:948-959.
35. McAllister C.E., Creech R.D., Kimball P.A., Muma N.A., Li Q. GPR30 is necessary for estradiol-induced desensitization of 5-HT(1A) receptor signaling in the paraventricular nucleus of the rat hypothalamus. Psychoneuroendocrinology 2012, 37:1248-1260.
36. Mize A.L., Young L.J., Alper R.H. Uncoupling of 5-HT1A receptors in the brain by estrogens: regional variations in antagonism by ICI 182,780. Neuropharmacology 2003, 44:584-591.
37. Palmer C.S., Osellame L.D., Stojanovski D., Ryan M.T. The regulation of mitochondrial morphology: intricate mechanisms and dynamic machinery. Cell Signal. 2011, 23:1534-1545.
38. Papoucheva E., Dumuis A., Sebben M., Richter D.W., Ponimaskin E.G. The 5-hydroxytryptamine (1A) receptor is stably palmitoylated, and acylation is critical for communication of receptor with Gi protein. J. Biol. Chem. 2004, 279:3280-3291.
39. Peckham E.M., Graves S.M., Jutkiewicz E., Becker J.B., Traynor J.R. Role of gonadal hormones on mu-opioid-stimulated [(3)(5)S]GTPgammaS binding and morphine-mediated antinociception in male and female Sprague-Dawley rats. Psychopharmacology 2011, 218:483-492.
40. Pucadyil T.J., Chattopadhyay A. Cholesterol modulates ligand binding and G-protein coupling to serotonin (1A) receptors from bovine hippocampus. Biochim. Biophys. Acta 2004, 1663:188-200.
41. Renner U., Glebov K., Lang T., Papusheva E., Balakrishnan S., Keller B., Richter D.W., Jahn R., Ponimaskin E. Localization of the mouse 5-hydroxytryptamine (1A) receptor in lipid microdomains depends on its palmitoylation and is involved in receptor-mediated signaling. Mol. Pharmacol. 2007, 72:502-513.
42. Rusakov D.A., Savtchenko L.P., Zheng K., Henley J.M. Shaping the synaptic signal: molecular mobility inside and outside the cleft. Trends Neurosci. 2011, 34:359-369.
43. Scheschonka A., Tang Z., Betz H. Sumoylation in neurons: nuclear and synaptic roles?. Trends Neurosci. 2007, 30:85-91.
44. Schmidt C., Kim D., Ippolito G.C., Naqvi H.R., Probst L., Mathur S., Rosas-Acosta G., Wilson V.G., Oldham A.L., Poenie M., Webb C.F., Tucker P.W. Signalling of the BCR is regulated by a lipid rafts-localised transcription factor, Bright. EMBO J. 2009, 28:711-724.
45. Serres F., Li Q., Garcia F., Raap D.K., Battaglia G., Muma N.A., Van de Kar L.D. Evidence that G(z)-proteins couple to hypothalamic 5-HT(1A) receptors in vivo. J. Neurosci. 2000, 20:3095-3103.
46. Valdizan E.M., Castro E., Pazos A. Agonist-dependent modulation of G-protein coupling and transduction of 5-HT1A receptors in rat dorsal raphe nucleus. Int. J. Neuropsychopharmacol. 2010, 13:835-843.
47. Wilkinson K.A., Henley J.M. Mechanisms, regulation and consequences of protein SUMOylation. Biochem. J. 2010, 428:133-145.
48. Wilkinson K.A., Nakamura Y., Henley J.M. Targets and consequences of protein SUMOylation in neurons. Brain Res. Rev. 2010, 64:195-212.
49. Wyatt D., Malik R., Vesecky A.C., Marchese A. Small ubiquitin-like modifier modification of arrestin-3 regulates receptor trafficking. J. Biol. Chem. 2011, 286:3884-3893.
50. Xu H., Qin S., Carrasco G.A., Dai Y., Filardo E.J., Prossnitz E.R., Battaglia G., DonCarlos L.L., Muma N.A. Extra-nuclear estrogen receptor GPR30 regulates serotonin function in rat hypothalamus. Neuroscience 2009, 158:1599-1607.
51. Yip S.C., Cotteret S., Chernoff J. Sumoylated protein tyrosine phosphatase 1B localizes to the inner nuclear membrane and regulates the tyrosine phosphorylation of emerin. J. Cell Sci. 2012, 125:310-316.